ArticleBreast cancer (Tokyo, Japan)2026
Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness).
Tomoe Taji et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.